Viewing Study NCT03751202


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2026-02-28 @ 10:35 PM
Study NCT ID: NCT03751202
Status: COMPLETED
Last Update Posted: 2018-12-28
First Post: 2018-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUSĀ® in Healthy Volunteers
Sponsor: Respirent Pharmaceuticals Co Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bioequivalence View
Keywords:

Keywords

Keyword Brief Keyword Text View
None inhaler View
None fluticasone proprionate View
None salmeterol xinafoate View
None ADVAIR DISKUS View